骨唾液酸蛋白与维持性血液透析患者腹主动脉钙化的关系

doi:10.3969/cndt.j.issn.1006-298X.2018.01.006

肾脏病与透析肾移植杂志 ›› 2018, Vol. 27 ›› Issue (1): 29-34.DOI: 10.3969/cndt.j.issn.1006-298X.2018.01.006

骨唾液酸蛋白与维持性血液透析患者腹主动脉钙化的关系

出版日期:2018-02-28 发布日期:2018-03-01

Between bone sialoprotein and abdominal aortic calcification in maintenance hemodialysis patients

Online:2018-02-28 Published:2018-03-01

摘要/Abstract

摘要：

目的：探讨血清骨唾液酸蛋白（BSP）与维持性血液透析（MHD）患者腹主动脉钙化的关系。
方法：选取2016年5月至2017 年2月于本院血液净化中心规律透析患者75例。检测患者血清BSP，并进行腹部侧位X平片拍摄，根据 kauppila半定量积分方法进行腹主动脉钙化评分（AACs），参考CORD分段方法，根据AAC得分将患者分为无或轻度钙化组(AACs≤4)、中度钙化组(5≤AACs≤15)和重度钙化组(AACs≥16)。Logistic回归分析MHD患者AAC的影响因素。受试者工作特征（ROC）曲线分析BSP对血管钙化的诊断价值。
结果：75例 MHD患者中发生腹主动脉钙化者56例（7467%），AACs中位数为4（0,24）分，血清BSP中位数为2012（1863,2421）ng/ml。中度钙化组、重度钙化组BSP水平均高于无或轻度钙化组[2243（1958,684）ng/ml、2199（1987,2618）ng/ml vs 1916（173,233）ng/ml,P<005]。Logistic 回归分析发现BSP是AAC的独立危险因素（OR=1175,95%CI 1004～1375,P<005）。ROC曲线分析发现，BSP诊断AAC的曲线下面积为0718（95%CI为0604～0833,P=0001），BSP诊断AAC的临界值为2151 ng/ml，灵敏度为 0711，特异度为0595。
结论：血清BSP水平和MHD患者AAC的严重程度相关，高水平的BSP是AAC的独立危险因素。BSP对MHD患者腹主动脉钙化具有潜在诊断价值。

关键词: 骨唾液酸蛋白, 维持性血液透析, 血管钙化

Abstract:

Ｏｂｊｅｃｔｉｖｅ：To evaluate the potential association of bone sialoprotein with the development of abdominal aortic calcification (AAC)in maintenance hemodialysis (MHD) patients.
Ｍｅｔｈｏｄｏｌｏｇｙ：Seventyfive patients who were on MHD between May 2016 and Feb 2017 in the dialysis center were enrolled.Serum bone sialoprotein was tested.AAC was measured by abdomen lateral plain.Kauppila score was used to assess the degree of CAC.Referring to CORD segmentation method,patients was divided into three groups: no or mild calcification group(AACs≤4),moderate calcification group(5≤AACs≤15) and severe group(AACs≥16).Logistic regression analysis was used to determine the risk factor of AAC in MHD patients.The diagnostic value of serum bone sialoprotein for AAC was assessed using receiver operator characteristic (ROC) curve.
Ｒｅｓｕｌｔｓ：AAC was present in 7467%（56/75）patients,the median AAC score was 4（0,24）.The median of serum bone sialoprotein was 2012（1863,2421）ng/ml.The serum bone sialoprotein levels were significantly elevated in moderate and severe calcification group compared to no or mild calcification group[2243（1958,2684）ng/ml and 2199（1987,2618）ng/ml vs 1916（173,233）ng/ml,P<005].Multivariate logistic regression analysis showed that serum bone sialoprotein level was independent risk factor for AAC (OR=1175,95%CI 1004～1375,P<005).The area under the ROC curve of serum bone sialoprotein for AAC was 0718 (95%CI 0604～0833,P=0001),sensitivity was 0711,and specificity was 0595 for a cutoff value of 2151 ng/mL.
Ｃｏｎｃｌｕｓｉｏｎ：
Serum bone sialoprotein level is associated with AAC.Serum bone sialoprotein level may have a diagnostic value for AAC in MHD patients.

Key words: bone sialoprotein, maintenance hemodialysis, vascular calcification

伍宏伟，张洋洋，余宗超，等. 骨唾液酸蛋白与维持性血液透析患者腹主动脉钙化的关系[J]. 肾脏病与透析肾移植杂志, 2018, 27(1): 29-34.

WU Hongwei, ZHANG Yangyang, YU Zongchao，et al. Between bone sialoprotein and abdominal aortic calcification in maintenance hemodialysis patients[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(1): 29-34.

[1]	甘言刚, 赵明明, 滕洁, 夏文亚, 张颖, 冯锦红, 孙东. 维持性血液透析患者左心室舒张功能障碍的危险因素及预测模型[J]. 肾脏病与透析肾移植杂志, 2021, 30(1): 31-36.
[2]	蒲蕾,杨鸿玲,何强,李贵森,冯韵霖. 容量评估预测维持性血液透析患者预后的价值[J]. 肾脏病与透析肾移植杂志, 2020, 29(6): 508-513.
[3]	ACTIVE研究工作组. 西那卡塞治疗中国维持性血液透析继发性甲状旁腺功能亢进的多中心临床研究（ACTIVE）方案[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 478-483.
[4]	邓中凤,陈萍,邹杨. 隐匿性乙型肝炎病毒感染血液透析患者的分子特性及转归[J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 328-.
[5]	陈颖,沈毅,贾玉敏,等. 糖尿病患者维持性血液透析生存分析及预测模型构建[J]. 肾脏病与透析肾移植杂志, 2020, 29(3): 201-207.
[6]	张慧,顾莺,赵蕊,等. 维持性血液透析在婴幼儿终末期肾病的应用[J]. 肾脏病与透析肾移植杂志, 2020, 29(3): 215-219.
[7]	张继强，陈峥，常保超，等. 应用腔内血管成形术更换血液透析长期导管[J]. 肾脏病与透析肾移植杂志, 2020, 29(2): 130-135.
[8]	池向耿,蔡琪,陈艳转,等. 维持性血液透析患者缺铁性贫血的危险因素及列线图模型建立[J]. 肾脏病与透析肾移植杂志, 2019, 28(6): 538-543.
[9]	陈佩玲，龚德华. 焦磷酸盐与慢性肾脏病血管钙化[J]. 肾脏病与透析肾移植杂志, 2019, 28(4): 369-373.
[10]	刘玉秋，张晓良，汤日宁，等. 钙性尿毒症性小动脉病[J]. 肾脏病与透析肾移植杂志, 2018, 27(3): 294-299.
[11]	马建超，杜璐贝，梁馨苓，等. 卡维地洛对糖尿病肾病血液透析患者心功能的影响[J]. 肾脏病与透析肾移植杂志, 2018, 27(2): 147-150.
[12]	陈佩玲,龚德华,徐斌,等. 维持性血液透析患者心血管钙化进展的相关影响因素分析[J]. 肾脏病与透析肾移植杂志, 2017, 26(5): 403-407.
[13]	徐丽霞，崔燕海，冯仲林，等. 维持性血液透析患者冠状动脉钙化及其进展的危险因素[J]. 肾脏病与透析肾移植杂志, 2017, 26(5): 408-413.
[14]	马潭涌,郝丽荣. 维持性血液透析患者腹主动脉钙化的相关因素分析[J]. 肾脏病与透析肾移植杂志, 2017, 26(5): 414-419.
[15]	夏菊花,王君如,蔡震川,等. 四川地区维持性血液透析人群慢性肾脏病矿物质与骨异常的多中心横断面研究[J]. 肾脏病与透析肾移植杂志, 2017, 26(5): 420-425.

ISSN 1006-298X CN 32-1425/R

骨唾液酸蛋白与维持性血液透析患者腹主动脉钙化的关系

Between bone sialoprotein and abdominal aortic calcification in maintenance hemodialysis patients

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价